Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm

Journal of Clinical Virology

Volumn 42, Issue 1, 2008, Pages 13-21

  Nobre, Rui Jorge ^a,b   de Almeida, Luís Pereira ^b,c   Martins, Teresa C ^a,c  

^a Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cervical cancer; Genotyping; HPV; Polymerase chain reaction (PCR); RFLP

Indexed keywords

POLYACRYLAMIDE GEL; VIRUS DNA;

ARTICLE; BIOINFORMATICS; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENETIC ALGORITHM; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNINDEXED SEQUENCE; VIRUS TYPING; WART VIRUS;

COMPUTATIONAL BIOLOGY; DNA FINGERPRINTING; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA;

EID: 42649100965     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.11.021     Document Type: Article

References (26)

1. Astori G., Arzese A., Pipan C., de Villiers E.M., and Botta G.A. Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res 50 (1997) 57-63
2. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L., Delius H., et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170 (1994) 1077-1085
3. Bosch F.X., Lorincz A., Muñoz N., Meijer C.J.L.M., and Shsh K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
4. Bozzetti M., Nonnenmacher B., Mielzinska I., Villa L., Lorincz A., Breitenbach V., et al. Comparison between Hybrid Capture II and polymerase chain reaction results among women at low-risk for cervical cancer. Ann Epidemiol 10 (2000) 466
5. Castle P.E., Schiffman M., Burk R.D., Wacholder S., Hildesheim A., Herrero R., et al. Restricted cross-reactivity of Hybrid Capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 11 (2002) 1394-1399
6. Cope J.U., Hildesheim A., Schiffman M.H., Manos M.M., Lorincz A.T., Burk R.D., et al. Comparison of the Hybrid Capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 35 (1997) 262-265
7. Coutlée F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40 (2002) 902-907
8. de Roda Husman A.M., Walboomers J.M.M., Van Den Brule A.J.C., Meijer C.J.L.M., and Snijders P.J.F. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (1997) 1057-1062
9. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
10. Giovanelli L., Lama A., Capra G., Giordano V., Arico P., and Ammatuna P. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol 42 (2004) 3861-3864
11. Gravitt P.E., Peyton C.L., Alessi Q., Wheeler C.M., Coutlée F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38 (2000) 357-361
12. Hildesheim A., Schiffman M.H., Gravitt P.E., Glass A.G., Greer C.E., Zhang T., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169 (1994) 235-240
13. Lorincz A.T. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 22 (1996) 629-636
14. Lungu O., Wright T.C., and Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 6 (1992) 145-152
15. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7 (1989) 209-214
16. Moore D.H. Cervical cancer. Obstet Gynecol 107 (2006) 1152-1161
17. Muñoz N., Bosch F.X., de Sanjosé S., et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52 (1992) 743-749
18. Muñoz N., Castellsagué X., González A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24S3 (2006) S1-S10
19. Naqvi S.H., Wajid S., and Mitra A.B. Restriction fragment length polymorphism of L1 amplicon using RsaI detects five different human papillomavirus types and their co-infections among women attending a gynaecological outpatient department. J Virol Methods 117 (2004) 91-95
20. Patti K., Kathleen M., and Anna-Lise W. The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 159 (2002) 159-170
21. Pizzighella S., Pisoni G., Bevilacqua F., Vaona A., and Palu G. Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection. J Virol Methods 55 (1995) 245-256
22. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 (2002) 89-97
23. Santiago E., Camacho L., Junquera M.L., and Vásquez F. Full HPV typing by a single restriction enzyme. J Clin Virol 25 (2006) 89-97
24. Smits H.L., Bollen L.J., Tjong-A-Hung S.P., Vonk J., van der Velden J., ten Kate F.J., et al. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol 33 (1995) 2631-2636
25. Van den Brule A.J., Meijer C.J., Bakels V., Kenemans P., and Walboomers J.M. Rapid detection of human papillomavirus in cervical scrapes by combined general-primer mediated and type-specific polymerase chain reaction. J Clin Microbiol 28 (1990) 2739-2743
26. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19